Blood vessel technology is recognized to have a novel “switch” as per a research at Kumamoto University.
The research staff systematically analyzed the epigenetic modifications in angiogenesis-stimulated vascular endothelial cells (blood vessels) to defy the standard epigenomic knowledge.
‘Unique epigenetic modifications accountable for stimulating angiogenesis-specific (blood vessel technology) genes are found by scientists. ,
It was discovered that induces a novel epigenetic modification (bivalent histone-mark change — particular to vital transcription components) genes important for angiogenesis and revealed that the histone modifiers accountable for this modification are important for postnatal angiogenesis.
The findings could maintain the potential to compile the epigenomic database for regular endothelial cells and selective epigenomic drug discovery to guard towards age-related vascular ailments.